210 related articles for article (PubMed ID: 27853642)
41. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.
Pende D; Parolini S; Pessino A; Sivori S; Augugliaro R; Morelli L; Marcenaro E; Accame L; Malaspina A; Biassoni R; Bottino C; Moretta L; Moretta A
J Exp Med; 1999 Nov; 190(10):1505-16. PubMed ID: 10562324
[TBL] [Abstract][Full Text] [Related]
42. Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers.
Elion DL; Jacobson ME; Hicks DJ; Rahman B; Sanchez V; Gonzales-Ericsson PI; Fedorova O; Pyle AM; Wilson JT; Cook RS
Cancer Res; 2018 Nov; 78(21):6183-6195. PubMed ID: 30224377
[TBL] [Abstract][Full Text] [Related]
43. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
Mavoungou E; Bouyou-Akotet MK; Kremsner PG
Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
[TBL] [Abstract][Full Text] [Related]
44. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.
Besse B; Charrier M; Lapierre V; Dansin E; Lantz O; Planchard D; Le Chevalier T; Livartoski A; Barlesi F; Laplanche A; Ploix S; Vimond N; Peguillet I; Théry C; Lacroix L; Zoernig I; Dhodapkar K; Dhodapkar M; Viaud S; Soria JC; Reiners KS; Pogge von Strandmann E; Vély F; Rusakiewicz S; Eggermont A; Pitt JM; Zitvogel L; Chaput N
Oncoimmunology; 2016 Apr; 5(4):e1071008. PubMed ID: 27141373
[TBL] [Abstract][Full Text] [Related]
45. The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients.
Li SS; Kyei SK; Timm-McCann M; Ogbomo H; Jones GJ; Shi M; Xiang RF; Oykhman P; Huston SM; Islam A; Gill MJ; Robbins SM; Mody CH
Cell Host Microbe; 2013 Oct; 14(4):387-97. PubMed ID: 24139398
[TBL] [Abstract][Full Text] [Related]
46. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells.
Xing R; Li L; Chen L; Gao Z; Wang H; Li W; Cui J; Tian G; Liang Q; Yu J; Sung JJ; Luo G; Gao H; Xu X; Yang H; Wang J; Zhang X; Wang JM; Huang J; Yu Y; Wang J; Lu Y
Oncogene; 2016 May; 35(20):2584-91. PubMed ID: 26364607
[TBL] [Abstract][Full Text] [Related]
47. Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.
Long A; Dominguez D; Qin L; Chen S; Fan J; Zhang M; Fang D; Zhang Y; Kuzel TM; Zhang B
J Immunol; 2018 Dec; 201(11):3456-3464. PubMed ID: 30373846
[TBL] [Abstract][Full Text] [Related]
48. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
Han Q; Hou Z; Yin C; Zhang C; Zhang J
Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
[TBL] [Abstract][Full Text] [Related]
50. BRAF
Lunavat TR; Cheng L; Einarsdottir BO; Olofsson Bagge R; Veppil Muralidharan S; Sharples RA; Lässer C; Gho YS; Hill AF; Nilsson JA; Lötvall J
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5930-E5939. PubMed ID: 28684402
[TBL] [Abstract][Full Text] [Related]
51. Critical Role of IRF-3 in the Direct Regulation of dsRNA-Induced Retinoic Acid-Inducible Gene-I (RIG-I) Expression.
Hayakari R; Matsumiya T; Xing F; Yoshida H; Hayakari M; Imaizumi T
PLoS One; 2016; 11(9):e0163520. PubMed ID: 27662626
[TBL] [Abstract][Full Text] [Related]
52. TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells.
Imaizumi T; Aizawa-Yashiro T; Watanabe S; Matsumiya T; Yoshida H; Tatsuta T; Xing F; Meng P; Hayakari R; Tsuruga K; Tanaka H
J Nephrol; 2013; 26(5):886-93. PubMed ID: 23559071
[TBL] [Abstract][Full Text] [Related]
53. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
54. Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists.
Jacobson ME; Becker KW; Palmer CR; Pastora LE; Fletcher RB; Collins KA; Fedorova O; Duvall CL; Pyle AM; Wilson JT
ACS Cent Sci; 2020 Nov; 6(11):2008-2022. PubMed ID: 33274278
[TBL] [Abstract][Full Text] [Related]
55. Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs.
Palmer CR; Jacobson ME; Fedorova O; Pyle AM; Wilson JT
Bioconjug Chem; 2018 Mar; 29(3):742-747. PubMed ID: 29350913
[TBL] [Abstract][Full Text] [Related]
56. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
57. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
58. Dependence of RIG-I Nucleic Acid-Binding and ATP Hydrolysis on Activation of Type I Interferon Response.
Baek YM; Yoon S; Hwang YE; Kim DE
Immune Netw; 2016 Aug; 16(4):249-55. PubMed ID: 27574504
[TBL] [Abstract][Full Text] [Related]
59. Distinct human circulating NKp30
Correia MP; Stojanovic A; Bauer K; Juraeva D; Tykocinski LO; Lorenz HM; Brors B; Cerwenka A
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5980-E5989. PubMed ID: 29895693
[TBL] [Abstract][Full Text] [Related]
60. The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.
Textor S; Bossler F; Henrich KO; Gartlgruber M; Pollmann J; Fiegler N; Arnold A; Westermann F; Waldburger N; Breuhahn K; Golfier S; Witzens-Harig M; Cerwenka A
Oncoimmunology; 2016 Jul; 5(7):e1116674. PubMed ID: 27622013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
